|4Feb 2, 5:18 PM ET

Caplan Vered 4

4 · Orgenesis Inc. · Filed Feb 2, 2022

Insider Transaction Report

Form 4
Period: 2022-01-28
Caplan Vered
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2022-01-28$0.01/sh+278,191$3,338278,191 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-01-28278,1910 total
    Exercise: $0.01Exp: 2022-07-10Common Stock (278,191 underlying)
Footnotes (1)
  • [F1]These options were awarded on July 10, 2012 under the Issuer's 2012 Stock Option Plan to purchase shares of common stock of the Issuer and vested in two equal annual installments.

Documents

1 file
  • 4
    ownership.xmlPrimary